...
teva-img

Teva Pharma Industries Ltd ADR, Common Stock

TEVA

NYQ

$16.25

-$0.01

(-0.06%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$18.40B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
NM
Volume info-icon
This is the total number of shares traded during the most recent trading day.
7.81M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
8.57M
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.91
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$7.42 L
$17.69 H
$16.25

About Teva Pharma Industries Ltd ADR, Common Stock

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; GRANIX; TRISENOX; LONQUEX; and TEVAGRASTIM/RATIOGRASTIM. In addition, it provides COPAXONE for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO for the treatment of neurodegenerative and movement disorders associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; ProAir RespiClick inhalation powder; QVAR for treatment for asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax, an inhaled corticosteroid and long-acting beta-agonist bronchodilator; and AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder. The company offers its OTC products under SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. It has collaboration agreements with MedinCell; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. The company was founded in 1901 and is based in Tel Aviv, Israel. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameTEVASectorS&P500
1-Week Return-4.19%-0.25%0.06%
1-Month Return-3.04%2.64%3.07%
3-Month Return15.17%-0.87%4.44%
6-Month Return55.21%7.88%15%
1-Year Return116.67%13.56%26.61%
3-Year Return58.54%21.42%33.33%
5-Year Return76.06%71.6%101.55%
10-Year Return-65.88%181.82%234.58%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue16.89B16.66B15.88B14.93B15.85B[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":98.64,"profit":true},{"date":"2021-12-31","value":94.02,"profit":true},{"date":"2022-12-31","value":88.38,"profit":true},{"date":"2023-12-31","value":93.84,"profit":true}]
Cost of Revenue9.35B8.93B8.28B7.95B8.20B[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":95.53,"profit":true},{"date":"2021-12-31","value":88.59,"profit":true},{"date":"2022-12-31","value":85.04,"profit":true},{"date":"2023-12-31","value":87.7,"profit":true}]
Gross Profit7.54B7.72B7.59B6.97B7.64B[{"date":"2019-12-31","value":97.55,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":98.3,"profit":true},{"date":"2022-12-31","value":90.27,"profit":true},{"date":"2023-12-31","value":98.96,"profit":true}]
Gross Margin44.63%46.37%47.83%46.72%48.25%[{"date":"2019-12-31","value":92.5,"profit":true},{"date":"2020-12-31","value":96.12,"profit":true},{"date":"2021-12-31","value":99.13,"profit":true},{"date":"2022-12-31","value":96.84,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Expenses4.82B4.67B4.50B4.28B4.45B[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":96.93,"profit":true},{"date":"2021-12-31","value":93.33,"profit":true},{"date":"2022-12-31","value":88.93,"profit":true},{"date":"2023-12-31","value":92.42,"profit":true}]
Operating Income2.80B3.05B3.20B2.80B433.00M[{"date":"2019-12-31","value":87.46,"profit":true},{"date":"2020-12-31","value":95.47,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":87.46,"profit":true},{"date":"2023-12-31","value":13.54,"profit":true}]
Total Non-Operating Income/Expense(4.94B)(8.42B)(3.50B)(6.83B)(2.15B)[{"date":"2019-12-31","value":-493900000000,"profit":false},{"date":"2020-12-31","value":-842200000000,"profit":false},{"date":"2021-12-31","value":-350200000000,"profit":false},{"date":"2022-12-31","value":-682800000000,"profit":false},{"date":"2023-12-31","value":-215200000000,"profit":false}]
Pre-Tax Income(1.26B)(4.41B)658.00M(3.06B)(624.00M)[{"date":"2019-12-31","value":-192.25,"profit":false},{"date":"2020-12-31","value":-669.6,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-465.81,"profit":false},{"date":"2023-12-31","value":-94.83,"profit":false}]
Income Taxes(278.00M)(168.00M)211.00M(638.00M)(65.00M)[{"date":"2019-12-31","value":-131.75,"profit":false},{"date":"2020-12-31","value":-79.62,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-302.37,"profit":false},{"date":"2023-12-31","value":-30.81,"profit":false}]
Income After Taxes(987.00M)(4.24B)447.00M(2.43B)(559.00M)[{"date":"2019-12-31","value":-220.81,"profit":false},{"date":"2020-12-31","value":-948.1,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-542.95,"profit":false},{"date":"2023-12-31","value":-125.06,"profit":false}]
Income From Continuous Operations(987.00M)(4.24B)447.00M(2.41B)(615.00M)[{"date":"2019-12-31","value":-220.81,"profit":false},{"date":"2020-12-31","value":-948.1,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-538.26,"profit":false},{"date":"2023-12-31","value":-137.58,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(999.00M)(3.99B)417.00M(2.35B)(559.00M)[{"date":"2019-12-31","value":-239.57,"profit":false},{"date":"2020-12-31","value":-956.83,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-564.27,"profit":false},{"date":"2023-12-31","value":-134.05,"profit":false}]
EPS (Diluted)2.402.572.582.532.56[{"date":"2019-12-31","value":93.02,"profit":true},{"date":"2020-12-31","value":99.61,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":98.06,"profit":true},{"date":"2023-12-31","value":99.22,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

TEVA
Cash Ratio 0.22
Current Ratio 0.89
Quick Ratio 0.61

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

TEVA
ROA (LTM) 4.84%
ROE (LTM) -9.67%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

TEVA
Debt Ratio Lower is generally better. Negative is bad. 0.82
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.17
Debt/Equity The higher the number, the more leverage the business employs, the riskier the investment typically is. 5.88

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

TEVA
Trailing PE NM
Forward PE 5.59
P/S (TTM) 0.99
P/B 1.99
Price/FCF 398
EV/R 2.05
EV/Ebitda 20.84
PEG NM

News

Teva Pharmaceutical Industries Limited: New AJOVY (fremanezumab) Migraine Prevention Data Challenges Treatment Pauses

4th interim analysis of PEARL real world migraine prevention study presented at 10th European Association of Neurology (EAN) congress in Helsinki New sub-analysis of PEARL data highlights potentia…

28 Jun, 2024 a 3:36 pm Finanz Nachrichten

Teva Introduces Aventrail, The Brand’s Most Innovative Trail Running Sandal | DECK Stock News

Teva unveils Aventrail, a trail running sandal with the fit of a shoe. Featuring W Strapping System, HYPER-COMF cushioning, and Spider Rubber® outsole for $145.

26 Jun, 2024 a 1:00 pm Stock Titan

Teva Introduces Aventrail, The Brand’s Most Innovative Trail Running Sandal

Teva, a division of Deckers Brands (NYSE: DECK), is continuing to push the boundaries in performance footwear, introducing the first-of-its-kind, trail running sandal built for an uninhibited run experience. Aventrail was created to bridge a gap in the trail running market between running sandals with minimal support and modern running shoes with underfoot innovation and cushion. Delivering the Jetzt den vollständigen Artikel lesen

26 Jun, 2024 a 1:00 pm Wallstreet:Online

Teva settles $750 million tax dispute with Israeli authorities

The deal with the Israel Tax Authority resolves all pending litigation related to taxes payable for the years from 2008 to 2020

25 Jun, 2024 a 4:19 pm CTECH

Teva settles tax dispute in Israel with $750 mln payment

Teva Pharmaceutical Industries has entered into a deal with the Israel Tax Authority to resolve all pending litigation related to taxes payable for the years from 2008 to 2020, the drugmaker said on Tuesday.

25 Jun, 2024 a 12:58 pm Reuters

Teva Reaches Agreement With the Israel Tax Authority to Resolve All Pending Litigation for the Company''s Taxable Years 2008-2020

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it has entered an agreement with the Israel Tax Authority (the "ITA") resolving all pending litigation with respect to taxes payable for the Company''s taxable years 2008-2020. Under the terms of the agreement the Company will pay a total of $750 million in installments between 2024 to 2029. This allows Teva to end Jetzt den vollständigen Artikel lesen

25 Jun, 2024 a 12:00 pm Wallstreet:Online

Teva Reaches Agreement With the Israel Tax Authority to Resolve All Pending Litigation for the Company''s Taxable Years 2008-2020 | TEVA Stock News

Teva resolves $750M tax dispute with Israel, settles litigation for 2008-2020; no impact on 2024 outlook. Focus shifts to ''Pivot to Growth'' strategy. Read more.

25 Jun, 2024 a 12:00 pm Stock Titan

The best flip flops with arch support

Wearing sandals without arch support can cause pain and discomfort. Experts recommended these sandals with arch support from brands like Birkenstock, Vionic, Teva and more.

24 Jun, 2024 a 8:22 pm NBC News

FAQs

What is Teva Pharma Industries Ltd ADR share price today?

Teva Pharma Industries Ltd ADR (TEVA) share price today is $16.25

Can Indians buy Teva Pharma Industries Ltd ADR shares?

Yes, Indians can buy shares of Teva Pharma Industries Ltd ADR (TEVA) on Vested. To buy Teva Pharma Industries Ltd ADR from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in TEVA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Teva Pharma Industries Ltd ADR be purchased?

Yes, you can purchase fractional shares of Teva Pharma Industries Ltd ADR (TEVA) via the Vested app. You can start investing in Teva Pharma Industries Ltd ADR (TEVA) with a minimum investment of $1.

How to invest in Teva Pharma Industries Ltd ADR shares from India?

You can invest in shares of Teva Pharma Industries Ltd ADR (TEVA) via Vested in three simple steps:

  • Click on Sign Up or Invest in TEVA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Teva Pharma Industries Ltd ADR shares
What is Teva Pharma Industries Ltd ADR 52-week high and low stock price?

The 52-week high price of Teva Pharma Industries Ltd ADR (TEVA) is $17.69. The 52-week low price of Teva Pharma Industries Ltd ADR (TEVA) is $7.42.

What is Teva Pharma Industries Ltd ADR price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Teva Pharma Industries Ltd ADR (TEVA) is NM

What is Teva Pharma Industries Ltd ADR price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Teva Pharma Industries Ltd ADR (TEVA) is 1.99

What is Teva Pharma Industries Ltd ADR dividend yield?

The dividend yield of Teva Pharma Industries Ltd ADR (TEVA) is 0.00%

What is the Market Cap of Teva Pharma Industries Ltd ADR?

The market capitalization of Teva Pharma Industries Ltd ADR (TEVA) is $18.40B

What is Teva Pharma Industries Ltd ADR’s stock symbol?

The stock symbol (or ticker) of Teva Pharma Industries Ltd ADR is TEVA

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top